Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J G Cory

Showing results (111-120 of 119) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 119 results.
Advances in Enzyme Regulation|January 1, 1985
The utility of combinations of drugs directed at specific sites of the same target enzyme--ribonucleotide reductase as the modelJ G Cory, A Sato, G L Carter, et al.
Biochimica Et Biophysica Acta|April 11, 1986
5'-Haloacetamido-5'-deoxythymidines: novel inhibitors of thymidylate synthaseB P Sani, A Vaid, J G Cory, et al.
Biochemical Pharmacology|October 15, 1990
Inhibition of ribonucleotide reductase and growth of human colon carcinoma HT-29 cells and mouse leukemia L1210 cells by N-hydroxy-N'-aminoguanidine derivativesM Matsumoto, J G Fox, P H Wang, et al.
Pharmaceutical Research|June 1, 1997
Cellular delivery of nucleoside diphosphates: a prodrug approachS H Kang, A K Sinhababu, J G Cory, et al.
Biochemical Pharmacology|July 19, 1994
Inhibitors of ribonucleotide reductase. Comparative effects of amino- and hydroxy-substituted pyridine-2-carboxaldehyde thiosemicarbazonesJ G Cory, A H Cory, G Rappa, et al.
Advances in Enzyme Regulation|January 1, 1995
Structure-function relationships for a new series of pyridine-2-carboxaldehyde thiosemicarbazones on ribonucleotide reductase activity and tumor cell growth in culture and in vivoJ G Cory, A H Cory, G Rappa, et al.
Biochemical Pharmacology|October 6, 1997
Overexpression of the multidrug resistance genes mdr1, mdr3, and mrp in L1210 leukemia cells resistant to inhibitors of ribonucleotide reductaseG Rappa, A Lorico, M C Liu, et al.
Clinical and Experimental Rheumatology|May 1, 1993
Lack of immunosuppressive effect of low-dose oral methotrexate on lymphocytes in rheumatoid arthritisP Martínez-Osuna, J B Zwolinska, D H Sikes, et al.
Journal of Medicinal Chemistry|July 1, 1984
Biological activity and a modified synthesis of 8-amino-3-beta-D-ribofuranosyl-1,2,4-triazolo[4,3-a]pyrazine, an isomer of formycinS W Schneller, R D Thompson, J G Cory, et al.
Pageof 12

Showing results (111-120 of 119) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 119 results.
Advances in Enzyme Regulation|January 1, 1985
The utility of combinations of drugs directed at specific sites of the same target enzyme--ribonucleotide reductase as the modelJ G Cory, A Sato, G L Carter, et al.
Biochimica Et Biophysica Acta|April 11, 1986
5'-Haloacetamido-5'-deoxythymidines: novel inhibitors of thymidylate synthaseB P Sani, A Vaid, J G Cory, et al.
Biochemical Pharmacology|October 15, 1990
Inhibition of ribonucleotide reductase and growth of human colon carcinoma HT-29 cells and mouse leukemia L1210 cells by N-hydroxy-N'-aminoguanidine derivativesM Matsumoto, J G Fox, P H Wang, et al.
Pharmaceutical Research|June 1, 1997
Cellular delivery of nucleoside diphosphates: a prodrug approachS H Kang, A K Sinhababu, J G Cory, et al.
Biochemical Pharmacology|July 19, 1994
Inhibitors of ribonucleotide reductase. Comparative effects of amino- and hydroxy-substituted pyridine-2-carboxaldehyde thiosemicarbazonesJ G Cory, A H Cory, G Rappa, et al.
Advances in Enzyme Regulation|January 1, 1995
Structure-function relationships for a new series of pyridine-2-carboxaldehyde thiosemicarbazones on ribonucleotide reductase activity and tumor cell growth in culture and in vivoJ G Cory, A H Cory, G Rappa, et al.
Biochemical Pharmacology|October 6, 1997
Overexpression of the multidrug resistance genes mdr1, mdr3, and mrp in L1210 leukemia cells resistant to inhibitors of ribonucleotide reductaseG Rappa, A Lorico, M C Liu, et al.
Clinical and Experimental Rheumatology|May 1, 1993
Lack of immunosuppressive effect of low-dose oral methotrexate on lymphocytes in rheumatoid arthritisP Martínez-Osuna, J B Zwolinska, D H Sikes, et al.
Journal of Medicinal Chemistry|July 1, 1984
Biological activity and a modified synthesis of 8-amino-3-beta-D-ribofuranosyl-1,2,4-triazolo[4,3-a]pyrazine, an isomer of formycinS W Schneller, R D Thompson, J G Cory, et al.
Pageof 12